Review: COVID-19 Vasculitis or Novel Vasculitis Mimic?
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
Vascular Medicine
Mortality Trends in Patients Hospitalized With High-Risk Pulmonary Embolism
Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.
Medtronic Stent Graft System Recalled Due to Fractures, Endoleaks
The recall was initiated due to reports of stent fractures and endoleaks.
Effect of Rituximab Timing on COVID-19-Related Death in ANCA-Associated Vasculitis
Treatment with rituximab and immunoglobulin levels may increase risk for COVID-19-related death in ANCA-associated vasculitis.
New Biomarkers Predict Mortality, Clinical Features of Infective Endocarditis
Researchers analyzed data from patients with a recent diagnosis of IE hospitalized to see whether PCT, proADM, and copeptin have prognostic value in IE compared with CRP, a known biomarker for IE.
Combined Benefits Seen With Exercise Plus Revascularization in LE Peripheral Artery Disease
A combination exercise therapy and revascularization may result in improved clinical outcomes vs either strategy alone in lower extremity PAD.
Long-Term Benefits of Beta-Blockers, ARBs, and ACEIs in Aortic Dissection
Beta-blocker and ARB or ACEI use is associated with benefits in the long-term treatment of aortic dissection.
CCO Predicts In-Hospital Events in Patients With Stenosis Undergoing CEA but Not CAS
This study sought to determine the clinical impact of contralateral carotid occlusion among patients undergoing carotid endarterectomy and coronary artery stenting.
CVD Risk Factors, Carotid Plaque Burden, and Brain Hypometabolism
The presence of cardiovascular risk factors and subclinical carotid atherosclerosis in midlife may be associated with brain hypometabolism.
Fibrin-Specific Nanogels May Improve Result in Disseminated Intravascular Coagulation
Results of a rodent model show that fibrin-specific core-shell nanogels with a tissue-type plasminogen activator warrants more study as a treatment for patients with DIC.
-
Loading...
-
Loading...
Next post in Vascular Medicine
